16-09-2024 17:09 via drugs.com

Ozempic Could Curb Progression of Diabetes-Linked Liver Disease

MONDAY, Sept. 16, 2024 -- Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
In a new decades-long study, veterans with diabetes...
Read more »